Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER)
Fabrice André(Inserm), Hervé Bonnefoi, Ludovic Lacroix(Centre National de la Recherche Scientifique), Anthony Gonçalvès(Centre National de la Recherche Scientifique), Magali Lacroix‐Triki(Université Paris-Saclay), Jacques Bonneterre(Université Lille Nord de France), David Gentien, Jean-Marc Ferrero(Centre Antoine Lacassagne), Thomas Bachelot(Centre Léon Bérard), Christelle Lévy(Centre François Baclesse), José Adélaı̈de(Centre de Recherche en Cancérologie de Marseille), Véronique Dièras(Institut Curie), Florence Dalenc(Institut Claudius Regaud), Claudia Lefeuvre(Centre Eugène Marquis), Frédéric Commo(Inserm), Mario Campone(Institut de Cancérologie de l'Ouest), Marta Jimenez(UniCancer Group), Mónica Arnedos, Pascale A. Cohen(Lyon 1 Université), Thomas Filleron(Institut universitaire du cancer de Toulouse Oncopole)
Cited by 410
Related Papers
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Palbociclib and Letrozole in Advanced Breast Cancer
|New England Journal of Medicine|2016|2.9k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
AACR Project GENIE: Powering Precision Medicine through an International Consortium
|Cancer Discovery|2017|2k